Hims launches $199 weight-loss shots at 85% discount to Wegovy
The wildly popular shots are protected by patents until at least 2032.
Stay updated with breaking news from Madison Muller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The wildly popular shots are protected by patents until at least 2032.
Weight-loss shots are highly effective, but preserving muscle during fat loss is now a key focus for drugmakers like Regeneron and Eli Lilly.
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackBuffett Praises Apple After Trimming It, Drops Paramount StakeTreasury Rally Risks Running Into a $125 Billion Brick WallFrance’s Macron Calls for Reset of Economic Ties With ChinaLamborghini Bros No More: Crypto Is Creating a New Wealth EffectThe shares
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
(Bloomberg) -- Companies selling unhealthy foods need to tweak their business models to counter the growing popularity of weight-loss drugs — or risk alienating investors, according to the latest Bloomberg Markets Live Pulse survey.Most Read from BloombergLargest Covid Vaccine Study Yet Finds Links to Health ConditionsCapital One to Buy Discover Financial in $35 Billion DealAmazon Deserves to Be Called Out for Swindling UsersWall Street’s Moelis Bet Big on the Middle East. Now He’s Cashing InSto